Related Experiment Video

Updated: Aug 25, 2026

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
07:28

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

[Treatment of acute myocardial infarction-state of the art]

C Bode1

  • 1Innere Medizin III, Universitätsklinik Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany.

Zeitschrift Fur Kardiologie
|March 17, 2004
PubMed

Insights

For ST-elevation myocardial infarction (STEMI), intracoronary intervention is superior to thrombolysis, reducing short- and long-term events. Maintaining a high frequency of percutaneous coronary angioplasty (PTCA) is crucial for optimal patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • ST-elevation myocardial infarction (STEMI) management involves comparing intracoronary interventions with thrombolysis.
  • Percutaneous coronary angioplasty (PTCA) has demonstrated significant benefits over traditional treatments.

Purpose of the Study:

  • To evaluate the comparative effectiveness of intracoronary intervention versus thrombolysis in acute STEMI.
  • To assess the impact of treatment center transfer and intervention frequency on patient outcomes.

Main Methods:

  • Analysis of clinical data comparing outcomes of intracoronary intervention and thrombolysis.
  • Evaluation of short- and long-term event rates, including major bleeding.
  • Assessment of outcomes based on patient transfer status and frequency of interventional procedures.

Main Results:

  • Intracoronary intervention shows clear superiority over thrombolysis in acute STEMI.
  • PTCA significantly reduces short- and long-term adverse events, excluding major bleeding.
  • Transfer to interventional centers does not significantly diminish overall benefits; early symptom onset (<3 hours) may equalize mortality outcomes.

Conclusions:

  • Intracoronary intervention, specifically PTCA, is the preferred treatment for acute STEMI due to superior outcomes.
  • Regular performance of intracoronary interventions is essential to maximize PTCA benefits.
  • Low intervention frequency negates the advantages of PTCA over thrombolysis.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...